Target intelligence / Profile preview

ZBTB20 antisense RNA 2 (ZBTB20-AS2)

Target
ZBTB20-AS2
Molecular classification
Long non-coding RNA (lncRNA)
01

Overview

ZBTB20 antisense RNA 2 (ZBTB20-AS2) is presumed to be a long non-coding RNA (lncRNA) transcribed from the antisense strand to the ZBTB20 gene locus. Antisense RNAs are often involved in the regulation of their sense gene partners, potentially through mechanisms such as transcriptional interference, RNA-RNA interactions, or chromatin modification, but there is no published functional or mechanistic data on ZBTB20-AS2 specifically. By contrast, the protein-coding gene ZBTB20 encodes a transcription factor involved in neural development, immune function, hepatic metabolism, and cancer, but these functions are not attributable to the antisense RNA species[1][2][3][5]. There is no evidence supporting the use of ZBTB20-AS2 as a therapeutic target, nor any drugs or disease biomarkers associated with it. The lack of concrete data suggests that ZBTB20-AS2 is an uncharacterized or possibly predicted annotation, rather than a functionally validated or clinically relevant molecular target.

Other names
ZBTB20-AS2
02

Mechanism of action

None known

03

Biological functions

Unknown
04

Disease associations

Unknown

Beyond the preview

Go deeper on ZBTB20 antisense RNA 2 (ZBTB20-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZBTB20 antisense RNA 2 (ZBTB20-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call